Literature DB >> 702334

Interaction of methadone and ethanol metabolism.

S A Borowsky, C S Lieber.   

Abstract

To determine whether there might be a physiologic basis for the abuse of ethanol by methadone maintenance patients, studies of methadone metabolism were conducted in vivo and in vitro after acute and chronic ethanol administration to rats. Acute administration of ethanol resulted in increased brain and liver concentrations of methadone at two time periods and decreased biliary output of pharmacologically active methadone measured by radioactive tracer technique with [3H]methadone. In vitro, ethanol inhibited N-demethylation of methadone by microsomes from livers of naive rats, with a Ki averaging 32 mM (146 mg/kl). Also, methadone metabolism was inhibited by carbon monoxide indicating cytochrome P-450 dependence as is the case for ethanol. Chronic administration of ethanol to rats led to decreased levels of unmetabolized methadone in brain and liver, in vivo, and to increased microsomal N-demethylation of methadone, in vitro, compared to pair-fed controls. Therefore, acute ethanol administration may enhance cerebral effects of methadone by interfering with degradation of methadone at liver microsomal sites. Chronic ethanol administration increases methadone metabolism by stimulating degradation in liver microsomes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702334

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 2.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 3.  Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Authors:  C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Interaction of ethanol with codeine metabolism in rat hepatocytes: a multicompartmental model.

Authors:  E Bodd; M H Green; C A Drevon; J Mørland
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jul-Sep       Impact factor: 2.441

Review 6.  Effects of ethanol on drug and metabolite pharmacokinetics.

Authors:  E A Lane; S Guthrie; M Linnoila
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 7.  Alcohol use in opioid agonist treatment.

Authors:  Seonaid Nolan; Jan Klimas; Evan Wood
Journal:  Addict Sci Clin Pract       Date:  2016-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.